Advertisement CPRIT, Roche partner for cancer research in Texas - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CPRIT, Roche partner for cancer research in Texas

The Cancer Prevention and Research Institute of Texas (CPRIT) and Roche have joined hands to ramp up the development of oncology-based cancer research projects in Texas.

As per the agreement, both the parties have decided to work together for identifying ventures and technologies from academia and early stage projects in Texas for strengthening R&D portfolio of Roche.

In connection with that, Roche and CPRIT will offer financial help to the new ventures.

The agreement further allows Roche to evaluate investment opportunities and will give access to its drug development, scientific knowledge, manufacturing, regulation, clinical studies and marketing expertise to the selected ventures.

CPRIT chief commercialization officer Jerry Cobbs said combining Roche’s expertise and resources with CPRIT’s cancer research portfolio presents an opportunity for promising cancer research discoveries and Texas bio-pharma start-ups to go global.